MSC INDUSTRIAL SUPPLY’S SARA DULSKI APPOINTED TO SERVE ON INDUSTRY SUPPLY ASSOCIATION BOARD OF DIRECTORS

MSC INDUSTRIAL SUPPLY CO. (NYSE: MSM),a premier distributor of Metalworking and Maintenance, Repair and Operations supplies to industrial customers throughoutNorth America, today announced that Sara Dulski, General Manager, Metalworking, has been appointed to serve on theIndustry Supply Association (ISA) Board of Directors. https://mma.prnewswire.com/media/2602934/MSC_Industrial_Supply_Co___Sara_Dulski___Headshot.jpg At MSC, Sara leads a portfolio that includes metalworking production tools and […]

RAMM Pharma Corp. Provides Update on Canapar

(CNSX:RAMM.CN),(CNSX:RAMM),(OTC US:RAMMF),(Other OTC:RAMMF), Not for Dissemination in the US or through US Newswire Services TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa,

Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA(R) (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

(NasdaqGM:ADAG), SAN DIEGO and SUZHOU, China, Jan. 21, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced it will share updated clinical data from ADG126 in microsatellite stable colorectal cancer (MSS CRC) at the ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco,

ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI

(NASDAQ:ALXO), Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune

Helium Evolution Announces 10-36 Well Encounters Helium and Drilling Update

(TSX-V:HEVI), CALGARY, Alberta, Jan. 21, 2025 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce that its farm-in partner, North American Helium Inc. (“NAH“), has successfully completed drilling operations and is proceeding with casing of the joint

Plymouth Industrial REIT Announces Tax Treatment of 2024 Dividends

(NYSE:PLYM), BOSTON, Jan. 21, 2025 (GLOBE NEWSWIRE) — Plymouth Industrial REIT, Inc. (NYSE: PLYM) announced the tax treatment of its 2024 dividends to common stockholders. The following table summarizes Plymouth Industrial REIT's dividends to stockholders of Common Stock CUSIP #729640102 traded on the NYSE under ticker symbol “PLYM” for the tax year ended December 31,

Interfield Global Software Inc. Provides Update Regarding Its Proposed Joint Venture With Abhi

(Neo:IFSS.NE), VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) — Interfield Global Software Inc. (CBOE CA: IFSS) (the “Company” or “Interfield”) is pleased to provide the following update regarding the implementation of its previously announced MOU dated November 15, 2024 between its wholly owned subsidiary, Interfield Software Solutions LLC (“IFSS LLC”) and Abhi to integrate

Wintrust Financial Corporation Reports Record Full Year Net Income

(NASDAQ:WTFC), ROSEMONT, Ill., Jan. 21, 2025 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”, “the Company”, “we” or “our”) (Nasdaq: WTFC) announced net income of $695.0 million or $10.31 per diluted common share for the year ended December 31, 2024 compared to net income of $622.6 million or $9.58 per diluted common share for the same

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Block

(NYSE:SQ), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Block To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Block between February 26, 2020 and April 30, 2024 and would like to discuss your legal rights, call Faruqi &

Scroll to Top